Specific β‐lactam antibiotics inhibit secretion of lipo‐β‐lactamase in yeast

A. London, O. Pines*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The β‐lactam antibiotic cloxacillin can inhibit secretion of prokaryotic lipo‐β‐lactamase into the periplasm of yeast. The results indicate that this phenomenon is specific with respect to both the antibiotic and the lipo‐β‐lactamase whose secretion is affected, strongly suggesting that this involves an interaction between the enzyme and its substrates. The effect of the antibiotic on secretion is reversible. With different β‐lactam antibiotics, the clearest difference is observed between type A and type S penicillins; the former exert a strong inhibition of secretion whereas the latter exhibit a weak effect or no effect at all. Type A penicillins have been previously shown to cause a conformational change in various β‐lactamases. Mature lipo‐β‐lactamase species in yeast were localized either to the periplasmic space or bound to the outer surface of the cytoplasmic membrane and thus exposed to periplasm. The results are consistent with the hypothesis that binding of cloxacillin to lipo‐β‐lactamase induces a conformation on the protein that is unfavourable for its release from the membrane.

Original languageAmerican English
Pages (from-to)2193-2200
Number of pages8
JournalMolecular Microbiology
Issue number12
StatePublished - Dec 1990


Dive into the research topics of 'Specific β‐lactam antibiotics inhibit secretion of lipo‐β‐lactamase in yeast'. Together they form a unique fingerprint.

Cite this